title: Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection.
abstract: Cerebral malaria (CM) is a serious and often fatal complication of Plasmodium falciparum infections; however, the precise mechanisms leading to CM is poorly understood. Mouse malaria models have provided insight into the key events in pathogenesis of CM. T-cell immune response is known to play an important role in malaria infection, and members of the T-cell immunoglobulin- and mucin-domain-containing molecule (Tim) family have roles in T-cell-mediated immune responses. Tim-1 and Tim-3 are expressed on terminally differentiated Th2 and Th1 cells, respectively, and participate in the regulation of Th immune response. Until now, the role of Tim family proteins in Plasmodium infection remains unclear. In the present study, the mRNA levels of Tim-1, Tim-3, and some key Th1 and Th2 cytokines in the spleen of Kunming outbred mice infected with Plasmodium berghei ANKA (PbANKA) were determined using real-time polymerase chain reaction (qRT-PCR). Compared with uninfected controls, Tim-1 expression was significantly decreased in infected mice with CM at day 10 postinfection (p.i.) but significantly increased in infected mice with non-CM at day 22 p.i.; in contrast, Tim-3 expression was significantly increased in infected mice both with CM at day 10 p.i. and with non-CM at day 22 p.i. The expressions of IFN-γ, TNF-α, IL-10, and IL-12 were significantly increased but IL-4 was significantly decreased in infected mice with CM at days 10 p.i., whereas the expressions of IFN-γ, TNF-α, IL-4, IL-10, and TGF-β were significantly increased but IL-12 was significantly decreased in infected mice with non-CM at days 22 p.i. Furthermore, the expression of Tim-1 and Tim-3 could reflect Th2 and Th1 immune response in the spleen of PbANKA-infected mice, respectively. Our data suggest that PbANKA infection could inhibit the differentiation of T lymphocytes toward Th2 cells, promote the Th1 cell differentiation, and induce Th1-biased immune response in the early infective stage, whereas the infection could promote Th2 cell differentiation and induce Th2-biased immune response in the late infective stage. Our data indicate that both Tim-1 and Tim-3 may play a role in the process of PbANKA infection, which may represent a potential therapeutic target.
authors: Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong Province 510080, China.
authors: Bo
authors: B
authors: Huang
authors: Man
authors: M
authors: Liu
authors: Shiguang
authors: S
authors: Huang
authors: Bin
authors: B
authors: Wu
authors: Hong
authors: H
authors: Guo
authors: Xin-Zhuan
authors: XZ
authors: Su
authors: Fangli
authors: F
authors: Lu
mesh_terms: D000818:Animals; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics; D004195:Disease Models, Animal; D005260:Female; D015870:Gene Expression; D020869:Gene Expression Profiling; D000072596:Hepatitis A Virus Cellular Receptor 1; D000072597:Hepatitis A Virus Cellular Receptor 2; D054884:Host-Pathogen Interactions; D016779:Malaria, Cerebral / Q000276:immunology / Q000473:pathology*; D008565:Membrane Proteins / Q000096:biosynthesis* / Q000235:genetics; D051379:Mice; D010962:Plasmodium berghei / Q000472:pathogenicity*; D060888:Real-Time Polymerase Chain Reaction; D011991:Receptors, Virus / Q000096:biosynthesis* / Q000235:genetics; D013154:Spleen / Q000276:immunology / Q000473:pathology; D018417:Th1 Cells / Q000276:immunology
chemical_list: D016207:Cytokines; C442240:Havcr1 protein, mouse; C442241:Havcr2 protein, mouse; D000072596:Hepatitis A Virus Cellular Receptor 1; D000072597:Hepatitis A Virus Cellular Receptor 2; D008565:Membrane Proteins; D011991:Receptors, Virus
references: Cytokine. 2008 Oct;44(1):9-13
references: 18706830
references: Ann Hum Genet. 2008 May;72(Pt 3):327-36
references: 18294362
references: Parasitol Today. 2000 Jan;16(1):18-23
references: 10637583
references: J Infect Dis. 1999 Jan;179(1):279-82
references: 9841855
references: Curr Top Microbiol Immunol. 2011;350:1-15
references: 20700701
references: Immunol Lett. 2011 Dec 30;141(1):28-35
references: 21911007
references: PLoS One. 2011;6(9):e25477
references: 21980474
references: J Immunol. 2010 Sep 15;185(6):3632-42
references: 20720206
references: Curr Top Microbiol Immunol. 2005;297:103-43
references: 16265904
references: Infect Immun. 1997 Nov;65(11):4883-7
references: 9353082
references: Science. 1987 Sep 4;237(4819):1210-2
references: 3306918
references: Lab Anim. 2009 Jan;43(1):34-40
references: 19141464
references: PLoS One. 2011;6(11):e27714
references: 22110737
references: Pediatrics. 2008 Jul;122(1):e92-9
references: 18541616
references: Annu Rev Immunol. 2005;23:69-99
references: 15771566
references: J Neurol Sci. 1991 Jan;101(1):35-46
references: 2027026
references: Infect Immun. 1997 Aug;65(8):3271-6
references: 9234786
references: Antioxid Redox Signal. 2011 May 1;14(9):1589-600
references: 21142608
references: J Immunol. 1989 Sep 15;143(6):2038-44
references: 2506274
references: Parasitol Res. 2011 Apr;108(4):807-14
references: 20978790
references: Springer Semin Immunopathol. 2004 Feb;25(3-4):335-48
references: 15007635
references: Trends Immunol. 2003 Sep;24(9):491-9
references: 12967673
references: Parasitol Res. 2012 Apr;110(4):1517-24
references: 21965043
references: Eur J Immunol. 2010 Feb;40(2):426-36
references: 19950183
references: Life Sci. 2008 Mar 12;82(11-12):663-9
references: 18234236
references: J Immunol. 1993 Nov 1;151(9):4811-20
references: 8409439
references: Infect Immun. 1996 Feb;64(2):535-41
references: 8550204
references: J Ethnopharmacol. 2011 Jan 27;133(2):654-62
references: 21040771
references: Clin Neuropathol. 1993 May-Jun;12(3):142-6
references: 8100753
references: Glia. 1997 Feb;19(2):135-51
references: 9034830
references: Am J Trop Med Hyg. 1994 Nov;51(5):642-7
references: 7985757
references: Nat Immunol. 2003 Nov;4(11):1093-101
references: 14556005
references: J Immunol. 2006 Feb 1;176(3):1411-20
references: 16424168
references: Lancet Infect Dis. 2002 Aug;2(8):472-8
references: 12150846